Squarepoint Ops LLC Reduces Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Squarepoint Ops LLC lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 88.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 15,730 shares of the medical instruments supplier's stock after selling 126,390 shares during the period. Squarepoint Ops LLC's holdings in DENTSPLY SIRONA were worth $299,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of XRAY. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at about $26,000. Colonial Trust Co SC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $26,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after purchasing an additional 1,568 shares in the last quarter. True Wealth Design LLC increased its stake in shares of DENTSPLY SIRONA by 866.7% in the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after purchasing an additional 1,950 shares in the last quarter. Finally, Quarry LP increased its stake in shares of DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after purchasing an additional 780 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Trading Up 1.1%

NASDAQ XRAY traded up $0.18 on Tuesday, reaching $16.41. The stock had a trading volume of 1,538,833 shares, compared to its average volume of 2,963,105. The firm has a market capitalization of $3.27 billion, a price-to-earnings ratio of -7.93, a P/E/G ratio of 1.80 and a beta of 0.95. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $27.95. The stock has a fifty day moving average price of $14.68 and a two-hundred day moving average price of $16.91.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. During the same quarter in the previous year, the company earned $0.42 earnings per share. The firm's quarterly revenue was down 7.8% compared to the same quarter last year. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date of this dividend is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on XRAY shares. Robert W. Baird cut their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Mizuho lowered their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Piper Sandler lowered their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. UBS Group lowered their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Finally, Wall Street Zen upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and an average target price of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.